Certara Products - Simcyp Archives | Page 22 of 22

Publication

Nowadays, 50-90% of drugs used in children have never been actually studied in this population. Consequently, either…

CertaraDecember 1, 2008

Publication

BACKGROUND: Erlotinib is an orally active antitumor agent. Analyses in vitro using human liver microsomes and…

CertaraJanuary 1, 2008

Publication

In adapting to the challenge to make more informed selection of compounds for development, the…

CertaraDecember 1, 2007

Certara Products – Simcyp